Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00229185
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
CJO | [(2R,4R)-2-[(1R,2R)-1-amino-2-hydroxypropyl]- 4-(4-hydroxybenzyl)-5-oxoimidazolidin- 1-yl]acetic acid | A | 2QT2 | 0.74 |  |
CTZ | C2-HYDROXY-COELENTERAZINE | A | 2HPS | 0.72 | |
| CTZ | C2-HYDROXY-COELENTERAZINE | A | 1EL4 | 0.72 | |
TYP | CYCLO-(L-TYROSINE-L-PROLINE) INHIBITOR | A,B | 1W1Y | 0.73 | |
CZH | C2-HYDROPEROXY-COELENTERAZINE | A | 1QV1 | 0.71 | |
| CZH | C2-HYDROPEROXY-COELENTERAZINE | A | 1JF2 | 0.71 | |
| CZH | C2-HYDROPEROXY-COELENTERAZINE | A | 1SL9 | 0.71 | |
| CZH | C2-HYDROPEROXY-COELENTERAZINE | A | 1JF0 | 0.71 | |
| CZH | C2-HYDROPEROXY-COELENTERAZINE | A | 1QV0 | 0.71 | |
| CZH | C2-HYDROPEROXY-COELENTERAZINE | A,B | 1EJ3 | 0.71 | |
NLT | N-DODECANOYL-L-TYROSINE | A,B,C,D,E,F, G,H | 2G0B | 0.72 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B | 2AH8 | 0.73 | |
| CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1HCJ | 0.73 | |
| CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1W7S | 0.73 | |
| CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1W7T | 0.73 | |
| CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B | 2AHA | 0.73 | |
| CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A | 1EME | 0.73 | |
| CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B | 1KP5 | 0.73 | |
| CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A | 1EMM | 0.73 | |
| CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A | 1EML | 0.73 | |
| CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1W7U | 0.73 | |
| CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1EMC | 0.73 | |
| CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A | 2HPW | 0.73 | |
OX3 | 4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME | A,B,C | 2OOH | 0.7 | |
CZO | [(2R,4S)-2-[(1S,2R)-1-amino-2-hydroxypropyl]- 2-hydroxy-4-(4-hydroxybenzyl)-5- oxoimidazolidin-1-yl]acetic acid | A | 2QRF | 0.73 | |
AOE | N-BUTYL-11-[(7R,8R,9S,13S,14S,17S)- 3,17-DIHYDROXY-13-METHYL-7,8,9,11,12,13,14,15,16,17- DECAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN- 7-YL]-N-METHYLUNDECANAMIDE | A | 1HJ1 | 0.7 | |
HDI | 3-(4-HYDROXYPHENYL)-4,5-DIHYDRO- 5-ISOXAZOLE-ACETIC ACID METHYL ESTER | A,B,C | 1LJT | 0.74 | |
CCY | 2-(1-AMINO-2-MERCAPTO-ETHYL)-5- (4-HYDROXY-BENZYL)-3-(ETHANOYL)- 3,5-DIHYDRO-IMIDAZOL-4-ONE | A | 1EMK | 0.7 | |
CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D | 1ZGO | 0.7 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E | 3CGL | 0.7 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D | 1G7K | 0.7 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D | 1GGX | 0.7 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A | 2ARL | 0.7 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E,F, G,H | 2C9I | 0.7 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A | 2VAD | 0.7 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D | 2H8Q | 0.7 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D | 1ZGP | 0.7 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E,F, G,H | 2IB5 | 0.7 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A | 1MOV | 0.7 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A | 1MOU | 0.7 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E,F, G,H | 2VAE | 0.7 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E,F, G,H | 2P4M | 0.7 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E,F, G,H | 2C9J | 0.7 | |
CFY | [(2S)-2-{(2R)-2-[(1S)-1-amino-2- phenylethyl]-2-hydroxy-2,5-dihydro- 1,3-thiazol-4-yl}-4-(4-hydroxybenzyl)- 5-oxo-2,5-dihydro-1H-imidazol-1- yl]acetic acid | A,B,C,D | 2ZMW | 0.7 | |
| CFY | [(2S)-2-{(2R)-2-[(1S)-1-amino-2- phenylethyl]-2-hydroxy-2,5-dihydro- 1,3-thiazol-4-yl}-4-(4-hydroxybenzyl)- 5-oxo-2,5-dihydro-1H-imidazol-1- yl]acetic acid | A | 2ZMU | 0.7 | |
CM1 | CARBOXYMYCOBACTIN S | A,B,C | 1X89 | 0.72 | |
TYC | L-TYROSINAMIDE | A | 2BF9 | 0.7 | |
| TYC | L-TYROSINAMIDE | A | 2OCI | 0.7 | |